Syringe Siliconization Process Investigation and Optimization

References

1. 1.↵
   1. Romacker M.,
   2. Shoenknecht T.

   The Rise of Prefilled Syringes from Niche Product to Primary Container of Choice: A Short History. Presented in a PDA Conference on The Universe of Pre-filled Syringes and Injection Devices, 2008, www.pda.org/prefilled2008 (accessed May 24, 2011).
2. 2.↵
   1. Jameel F.,
   2. Hershenson S.

   1. Swift R.

   Prefilled Syringes for Biopharmaceuticals. In Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals; Jameel F., Hershenson S. Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2010; pp 897– 913.
3. 3.↵
   1. Overcashier D. E.,
   2. Chan E. K.,
   3. Hsu C. C.

   Technical considerations in the development of prefilled syringes for protein products. Am. Pharm. Rev. 2006, 9 (6), 77–83.

   OpenUrl
4. 4.↵
   1. Badkar A.,
   2. Wolf A.,
   3. Boback L.,
   4. Kohle P.

   Development of biotechnology products in pre-filled syringes: technical considerations and approaches. AAPS PharmSciTech 2011, online publication, DOI: 10.1208/s12249-011-9617-y.
5. 5.↵
   1. Sardella A.

   Fine tuning of process parameters for improving biocompatibility of prefilled syringes. ONdrugDELIVERY (www.ondrugdelivery.com) 2010, “Prefilled Syringes: New Idea for the New Decade” issue, 18–22.
6. 6.↵
   1. Yin F.,
   2. Gland T.,
   3. Marquardt D.,
   4. Lux B.,
   5. McGarvey B.,
   6. Roe M.,
   7. Van Scoik K.

   Glass Siliconization: Development and Characterization. Presented in a PDA Conference on The Universe of Pre-filled Syringes and Injection Devices, Las Vegas, NV, October 18–21, 2010, http://www.pda.org/Presentation/The-Universe-of-Pre-filled-Syringes-and-Injection-Devices—Missing-Presentations/Fangdong-Yin.aspx (accessed May 24, 2011).
7. 7.↵
   1. Jones L. S.,
   2. Kaufmann A.,
   3. Middugh C. R.

   Silicone oil induced aggregation of proteins. J. Pharm. Sci. 2005, 94 (4), 918–927.

   OpenUrlPubMed
8. 8.↵
   1. Thirumangalathu R.,
   2. Krishnan S.,
   3. Speed-Ricci M.,
   4. Brems D.,
   5. Randolph T. W.,
   6. Carpenter J. F.

   Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. J. Pharm. Sci. 2009, 98 (9), 3167–3181.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ludwig D. B.,
   2. Carpenter J. F.,
   3. Hamel J. B.,
   4. Randolph T. W.

   Protein adsorption and excipient effects on kinetic stability of silicone oil emulsions. J. Pharm. Sci. 2010, 99 (4), 1721–1733.

   OpenUrlPubMedWeb of Science
10. 10.↵
    1. Narhi L. O.,
    2. Jiang Y.,
    3. Cao S.,
    4. Benedek K.,
    5. Shnek D. A.

    A critical review of analytical methods for subvisible and visible particles. Curr. Pharm. Biotechnol. 2009, 10 (4), 373–381.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Eakins M. N.

    Trends in the availability, siliconization, filling, inspection and labelling of pre-filled syringes. Am. Pharm Rev. 2009, 12 (3), 45–50.

    OpenUrl